Pain syndrome therapy in patients after mammoplasty

Author:

Muradov N. M.1ORCID,Sabazbekov Ch. S.1ORCID

Affiliation:

1. DR. SABAZBEKOV Plastic Surgery Clinic

Abstract

Purpose of the study: to study the efficacy and safety of the intravenous form of ibuprofen “Intrafen” 800 mg in patients after mammoplasty.Material and methods. The use of intravenous ibuprofen “Intrafen” 800 mg on the day of surgery for 200.0 0.9% sodium chloride solution and the next day in 27 patients of the main group after mammoplasty at the Clinic of Plastic Surgery DR. SABAZBEKOV" (Almaty, the Republic of Kazakhstan). The inclusion criterion was informed consent to mammoplasty and the absence of contraindications to the administration of Intrafen according to the instructions. The control group also consisted of 27 patients who underwent mammoplasty; as non-steroidal antiinflammatory drugs, they were prescribed a solution of ketoprofen 100 mg/day intramuscularly once.Result and discussion. The following types of plastic surgery on the mammary glands were performed: augmentation mammoplasty – 8 (29.6%), reduction mammoplasty – 10 (37.0%) and isolated mastopexy – 9 (33.4%). The intensity of pain on the VAS scale on the day of surgery was (4.5 ± 0.5) points, on the 1st day the relief was up to (1.4 ± 0.5) points. Hemodynamic parameters within 1 day were within normal limits: systolic blood pressure (113.9 ± 7.0) mm Hg, diastolic blood pressure (73.2 ± 6.47) mm Hg, heart rate (79.1 ± 4,9) beats per minute, saturation (99.6 ± 0.68) %. No gastrointestinal disturbances were found in the control group. The intensity of pain syndrome after surgery was (8.4 ± 1.3) points according to the VAS, which required the administration of an opioid solution of tramadol hydrochloride 100 mg/day and on the day of discharge the VAS was (4.1 ± 0.75) points, followed by the appointment of a solution of ketoprofen 100 mg/day once.Conclusion. The intravenous form of ibuprofen “Intrafen” 800 mg once a day of surgery and then 1600 mg/day during the day is effective for relieving pain in patients after mammoplasty and is safe due to the absence of adverse events from the gastrointestinal tract and stable hemodynamics.

Publisher

Research Institute of Microsurgery

Reference10 articles.

1. Fajzullin T.R. Vliyanie fazy menstrual`nogo cikla na rezul`tat augmentacionnoy mammoplastiki [The effect of the menstrual cycle phase on the result of augmentation mammoplasty]. Vestnik Avicenny’ – Avicenna’s Bulletin. 2021;23(2):208-215 (in Russ.). https://doi.org/10.25005/2074-0581-2021-23-2-208-215

2. Voblaya I.N., Koroleva N.V., Moreeva E.G. Marketingovyy analiz rynka plasticheskoy hirurgii v Rossii [Marketing analysis of the plastic surgery market in Russia]. Problemy social’noy gigieny, zdravooxraneniya i istorii mediciny – Problems of Social Hygiene, Public Health and History of Medicine. 2020;28(2):227-233 (in Russ.). http://dx.doi.org/10.32687/0869-866X-2020-28-2-227-233

3. Ovechkin A.M. Bol` i plasticheskaya hirurgiya: kak izbezhat` problem na puti k sovershenstvu [Pain and plastic surgery: how to avoid problems on the way to perfection] Klinicheskaya i eksperimentalnaya hirurgiya. Zhurn. im. akad. B.V. Petrovskogo – Clinical and Experimental Surgery. B.V. Petrovsky Journal. 2016;3(13):51-63 (in Russ.).

4. Petrova N.N., Kalakuczkiy N.V., Palatina O.M. Klinicheskaya i psixosocial`naya harakteristika pacientov plasticheskoy hirurgii [Clinical and psychosocial characteristics of plastic surgery patients]. Rossijskiy medicinskiy zhurnal – Russian Medical Journal. 2017;23(6):315-320 (in Russ.). http://dx.doi.org/10.18821/0869-21062017-23-6-315-320

5. Ovechkin A.M., Zvizhuleva A.A. Posleoperacionnoe obezbolivanie v plasticheskoy hirurgii [Postoperative anesthesia in plastic surgery]. Regionarnaya anesteziya i lechenie ostroy boli – Regional Anesthesia and Treatment of Acute Pain. – 2016;10(2):82-96. (in Russ.). https://doi.org/10.18821/1993-6508-2016-10-2-82-96

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3